{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:51:46Z","timestamp":1793235106972,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127338","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T14:43:37Z","timestamp":1748961817000},"page":"127338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["RSV vaccines and Guillain-Barr\u00e9 syndrome: Insights into an emerging concern"],"prefix":"10.1016","volume":"61","author":[{"given":"Cleo","family":"Anastassopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios-Periklis","family":"Panagiotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos","family":"Ferous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127338_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/vaccines13020097","article-title":"Development, current status, and remaining challenges for respiratory syncytial virus vaccines","volume":"13","author":"Anastassopoulou","year":"2025","journal-title":"Vaccines"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127338_bb0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/vaccines13040354","article-title":"Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines","volume":"2025","author":"Anastassopoulou","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127338_bb0015","article-title":"Surveillance of RSV","author":"CDC","year":"2024","journal-title":"Respiratory Syncytial Virus Infect (RSV)"},{"key":"10.1016\/j.vaccine.2025.127338_bb0020","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1016\/j.vaccine.2018.05.119","article-title":"Vaccine-preventable diseases, vaccines and Guillain-Barre\u2019 syndrome","volume":"37","author":"Principi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127338_bb0025","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127338_bb0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain-Barr\u00e9 syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127338_bb0035","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain-Barr\u00e9 syndrome and influenza vaccines: A meta-analysis","volume":"33","author":"Mart\u00edn Arias","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127338_bb0040","article-title":"Guillain-Barr\u00e9 Syndrome and Flu Vaccine","author":"CDC","year":"2024","journal-title":"Influenza (Flu)"},{"key":"10.1016\/j.vaccine.2025.127338_bb0045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12026-022-09316-6","article-title":"Guillain-Barr\u00e9 syndrome in association with COVID-19 vaccination: a systematic review","volume":"70","author":"Abolmaali","year":"2022","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2025.127338_bb0050","author":"Dunleavy"},{"key":"10.1016\/j.vaccine.2025.127338_bb0055","first-page":"73","article-title":"Early safety findings among persons aged \u226560 years who received a respiratory syncytial virus vaccine \u2014 United States, may 3, 2023\u2013April 14, 2024","author":"Hause","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127338_bb0060","article-title":"Respiratory syncytial virus (RSV) vaccine safety","author":"CDC","year":"2024","journal-title":"Vaccine Safety"},{"key":"10.1016\/j.vaccine.2025.127338_bb0065","article-title":"Evaluation of Guillain-Barr\u00e9 syndrome following respiratory syncytial virus vaccination among medicare beneficiaries 65 years and older","author":"Lloyd","year":"2025","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127338_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barr\u00e9 syndrome","volume":"32","author":"Haber","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2025.127338_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.it.2022.02.003","article-title":"Guillain-Barr\u00e9 syndrome: expanding the concept of molecular mimicry","volume":"43","author":"Laman","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2025.127338_bb0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s12031-020-01720-7","article-title":"A review of the role of genetic factors in Guillain-Barr\u00e9 syndrome","volume":"71","author":"Safa","year":"2021","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.vaccine.2025.127338_bb0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.05.018","article-title":"Susceptibility to Guillain\u2013Barr\u00e9 syndrome is associated to polymorphisms of CD1 genes","volume":"177","author":"Caporale","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.vaccine.2025.127338_bb0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12026-016-8817-7","article-title":"HLA-DRB1 the notorious gene in the mosaic of autoimmunity","volume":"65","author":"Arango","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2025.127338_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102665","article-title":"Genetic polymorphisms in Guillain-Barr\u00e9 syndrome: a field synopsis and systematic meta-analysis","volume":"19","author":"Zhao","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2025.127338_bb0100","first-page":"OD16","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain-Barr\u00e9 syndrome","volume":"11","author":"James","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.vaccine.2025.127338_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/cjn.2024.27","article-title":"Hyponatremia in Guillain-Barre syndrome: a review of its pathophysiology and management","volume":"52","author":"Netto","year":"2025","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.vaccine.2025.127338_bb0110","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1186\/s12879-021-06690-8","article-title":"The syndrome of inappropriate antidiuresis after vaccination against COVID-19: case report","volume":"21","author":"Lindner","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127338_bb0115","article-title":"Severe hyponatremia with consciousness disturbance after receiving SARS-CoV-2 mRNA vaccination","volume":"2023","author":"Kumagai","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.vaccine.2025.127338_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/pgmj.47.552.651","article-title":"Inappropriate secretion of antidiuretic hormone in Guillain-Barr\u00e9 syndrome","volume":"47","author":"Davies","year":"1971","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.vaccine.2025.127338_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66999-7","article-title":"Exploring the adverse events of Oxford\u2013AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain\u2013Barr\u00e9 Syndrome","volume":"14","author":"Meo","year":"2024","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T21:22:19Z","timestamp":1755897739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":25,"alternative-id":["S0264410X25006358"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127338","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RSV vaccines and Guillain-Barr\u00e9 syndrome: Insights into an emerging concern","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127338"}}